 Scott Saunders
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transportation of Patients | 2 | 2026 | 65 | 0.820 |
Why?
| | Naltrexone | 1 | 2024 | 115 | 0.780 |
Why?
| | Escherichia coli | 2 | 2026 | 835 | 0.780 |
Why?
| | Oligonucleotides | 1 | 2024 | 153 | 0.770 |
Why?
| | Plasmids | 1 | 2024 | 373 | 0.760 |
Why?
| | Bone Morphogenetic Proteins | 3 | 2014 | 143 | 0.750 |
Why?
| | Narcotic Antagonists | 1 | 2024 | 203 | 0.730 |
Why?
| | Biofilms | 2 | 2021 | 292 | 0.660 |
Why?
| | Pyocyanine | 1 | 2020 | 5 | 0.650 |
Why?
| | Osteogenesis | 2 | 2014 | 204 | 0.550 |
Why?
| | Alcoholism | 1 | 2024 | 822 | 0.530 |
Why?
| | Pseudomonas aeruginosa | 1 | 2020 | 395 | 0.510 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1193 | 0.480 |
Why?
| | Pediatrics | 2 | 2026 | 1121 | 0.480 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2014 | 8 | 0.420 |
Why?
| | Hospitalization | 1 | 2024 | 2460 | 0.410 |
Why?
| | Heparan Sulfate Proteoglycans | 2 | 2005 | 23 | 0.400 |
Why?
| | DNA | 1 | 2020 | 1435 | 0.400 |
Why?
| | Phenazines | 2 | 2024 | 17 | 0.370 |
Why?
| | Glypicans | 2 | 2009 | 11 | 0.360 |
Why?
| | Femur | 1 | 2014 | 254 | 0.360 |
Why?
| | Glycoproteins | 1 | 2014 | 354 | 0.360 |
Why?
| | Telemedicine | 1 | 2020 | 961 | 0.320 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 38 | 0.300 |
Why?
| | Oxidation-Reduction | 2 | 2024 | 1067 | 0.280 |
Why?
| | Coronary Vessels | 1 | 2009 | 246 | 0.260 |
Why?
| | Electron Transport | 3 | 2024 | 110 | 0.250 |
Why?
| | Transcription Factors | 2 | 2024 | 1734 | 0.250 |
Why?
| | Proteins | 2 | 2003 | 1023 | 0.240 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2026 | 19 | 0.240 |
Why?
| | Adrenal Gland Diseases | 1 | 2006 | 5 | 0.240 |
Why?
| | Neonatal Sepsis | 1 | 2026 | 9 | 0.240 |
Why?
| | Polymorphism, Genetic | 2 | 2006 | 614 | 0.230 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 499 | 0.230 |
Why?
| | Adrenal Glands | 1 | 2006 | 76 | 0.230 |
Why?
| | Heart | 1 | 2009 | 626 | 0.230 |
Why?
| | Air Ambulances | 1 | 2026 | 56 | 0.220 |
Why?
| | Escherichia coli Infections | 1 | 2026 | 125 | 0.220 |
Why?
| | Osteoclasts | 1 | 2005 | 54 | 0.220 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2006 | 107 | 0.220 |
Why?
| | Injections, Intramuscular | 1 | 2024 | 146 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 154 | 0.210 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 207 | 0.210 |
Why?
| | Sulfatases | 1 | 2003 | 5 | 0.200 |
Why?
| | Hematopoiesis | 1 | 2005 | 193 | 0.200 |
Why?
| | Bone Marrow Cells | 1 | 2005 | 321 | 0.200 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 119 | 0.200 |
Why?
| | Genetic Engineering | 1 | 2024 | 88 | 0.200 |
Why?
| | Infant, Newborn | 7 | 2026 | 6447 | 0.200 |
Why?
| | Electrodes | 2 | 2021 | 111 | 0.200 |
Why?
| | Genome, Bacterial | 1 | 2024 | 123 | 0.200 |
Why?
| | Integrases | 1 | 2024 | 122 | 0.200 |
Why?
| | Soil Microbiology | 1 | 2024 | 115 | 0.190 |
Why?
| | Patient Transfer | 1 | 2026 | 211 | 0.190 |
Why?
| | Neurology | 1 | 2024 | 116 | 0.180 |
Why?
| | Genetic Testing | 1 | 2005 | 480 | 0.180 |
Why?
| | Mutation | 3 | 2014 | 4075 | 0.180 |
Why?
| | Administration, Oral | 1 | 2024 | 866 | 0.180 |
Why?
| | Homeodomain Proteins | 1 | 2006 | 523 | 0.180 |
Why?
| | Geobacter | 1 | 2021 | 4 | 0.170 |
Why?
| | Methadone | 1 | 2023 | 122 | 0.170 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 591 | 0.170 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.170 |
Why?
| | Heart Defects, Congenital | 1 | 2009 | 910 | 0.170 |
Why?
| | Extracellular Space | 1 | 2021 | 117 | 0.170 |
Why?
| | Education, Medical | 1 | 2024 | 275 | 0.160 |
Why?
| | Genetic Predisposition to Disease | 2 | 2006 | 2378 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2003 | 314 | 0.160 |
Why?
| | Electrochemical Techniques | 1 | 2020 | 55 | 0.160 |
Why?
| | Sepsis | 1 | 2026 | 664 | 0.150 |
Why?
| | Infant, Premature, Diseases | 1 | 2020 | 113 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2020 | 531 | 0.140 |
Why?
| | Obstetric Labor, Premature | 1 | 2019 | 39 | 0.140 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 333 | 0.140 |
Why?
| | Medically Underserved Area | 1 | 2019 | 100 | 0.140 |
Why?
| | Chondrocytes | 2 | 2014 | 232 | 0.130 |
Why?
| | Animals, Newborn | 2 | 2026 | 891 | 0.130 |
Why?
| | Program Development | 1 | 2020 | 368 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2005 | 2046 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 558 | 0.120 |
Why?
| | Risk Assessment | 1 | 2005 | 3747 | 0.110 |
Why?
| | Carrier Proteins | 3 | 2005 | 728 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 602 | 0.110 |
Why?
| | Physicians | 1 | 2023 | 955 | 0.100 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 78 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2005 | 1957 | 0.100 |
Why?
| | Infant | 3 | 2026 | 10077 | 0.100 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 234 | 0.100 |
Why?
| | Osteoblasts | 1 | 2014 | 145 | 0.100 |
Why?
| | Substance Abuse Detection | 1 | 2014 | 110 | 0.100 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2003 | 44 | 0.090 |
Why?
| | CHO Cells | 2 | 2003 | 169 | 0.090 |
Why?
| | Humans | 13 | 2026 | 145474 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 376 | 0.090 |
Why?
| | Cricetinae | 2 | 2003 | 305 | 0.090 |
Why?
| | Wnt Signaling Pathway | 1 | 2014 | 211 | 0.090 |
Why?
| | Mice | 4 | 2026 | 18329 | 0.090 |
Why?
| | Heparin | 2 | 2003 | 247 | 0.080 |
Why?
| | Microscopy, Fluorescence | 2 | 2003 | 408 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 425 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2014 | 5983 | 0.080 |
Why?
| | Animals | 6 | 2026 | 38030 | 0.080 |
Why?
| | Female | 7 | 2026 | 78844 | 0.080 |
Why?
| | Child | 4 | 2026 | 22707 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 587 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2009 | 3124 | 0.080 |
Why?
| | Bone Density | 1 | 2014 | 487 | 0.080 |
Why?
| | Pregnancy | 4 | 2026 | 7202 | 0.080 |
Why?
| | Patched Receptors | 1 | 2009 | 14 | 0.080 |
Why?
| | Gestational Age | 2 | 2020 | 987 | 0.080 |
Why?
| | Male | 5 | 2026 | 72842 | 0.070 |
Why?
| | Child, Preschool | 2 | 2020 | 11853 | 0.070 |
Why?
| | Cell Membrane | 2 | 2003 | 707 | 0.070 |
Why?
| | Fistula | 1 | 2009 | 49 | 0.070 |
Why?
| | Hedgehog Proteins | 1 | 2009 | 200 | 0.070 |
Why?
| | Prospective Studies | 1 | 2020 | 8057 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2009 | 372 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6066 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2014 | 2507 | 0.060 |
Why?
| | Steroidogenic Factor 1 | 1 | 2006 | 13 | 0.060 |
Why?
| | Apgar Score | 1 | 2006 | 21 | 0.060 |
Why?
| | Term Birth | 1 | 2006 | 25 | 0.060 |
Why?
| | Cross Reactions | 1 | 2026 | 130 | 0.060 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 9 | 0.060 |
Why?
| | Collagen Type X | 1 | 2005 | 14 | 0.060 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2026 | 62 | 0.060 |
Why?
| | Galactosides | 1 | 2005 | 9 | 0.060 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2005 | 20 | 0.060 |
Why?
| | Receptors, Fc | 1 | 2026 | 54 | 0.060 |
Why?
| | RANK Ligand | 1 | 2005 | 27 | 0.060 |
Why?
| | Probiotics | 1 | 2026 | 61 | 0.060 |
Why?
| | Bromodeoxyuridine | 1 | 2005 | 77 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 62 | 0.060 |
Why?
| | Antibodies, Bacterial | 1 | 2026 | 147 | 0.060 |
Why?
| | Rare Diseases | 1 | 2006 | 116 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1102 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 22529 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2005 | 318 | 0.050 |
Why?
| | Myocytes, Cardiac | 1 | 2009 | 546 | 0.050 |
Why?
| | Adult | 2 | 2024 | 40777 | 0.050 |
Why?
| | Citrobacter | 1 | 2024 | 3 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 407 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 65 | 0.050 |
Why?
| | Gene Frequency | 1 | 2005 | 487 | 0.050 |
Why?
| | Nitrous Acid | 1 | 2003 | 7 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2003 | 90 | 0.050 |
Why?
| | Disaccharides | 1 | 2003 | 21 | 0.050 |
Why?
| | Monosaccharides | 1 | 2003 | 13 | 0.050 |
Why?
| | Signal Transduction | 2 | 2009 | 5216 | 0.050 |
Why?
| | Wnt Proteins | 1 | 2003 | 133 | 0.050 |
Why?
| | Middle Aged | 1 | 2024 | 36215 | 0.050 |
Why?
| | Faculty | 1 | 2023 | 147 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2026 | 892 | 0.040 |
Why?
| | Electricity | 1 | 2021 | 26 | 0.040 |
Why?
| | Delphi Technique | 1 | 2023 | 332 | 0.040 |
Why?
| | Transfection | 1 | 2003 | 926 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2009 | 2803 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 855 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2005 | 1162 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1179 | 0.040 |
Why?
| | Indoles | 1 | 2005 | 507 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 477 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1716 | 0.040 |
Why?
| | Opiate Substitution Treatment | 1 | 2023 | 188 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2006 | 713 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 633 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 624 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 972 | 0.040 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2020 | 75 | 0.040 |
Why?
| | Cerebral Hemorrhage | 1 | 2020 | 125 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 553 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 732 | 0.030 |
Why?
| | United States | 3 | 2019 | 16098 | 0.030 |
Why?
| | Prevalence | 1 | 2005 | 2865 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2023 | 562 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2024 | 967 | 0.030 |
Why?
| | Communication | 1 | 2024 | 975 | 0.030 |
Why?
| | Apoptosis | 1 | 2005 | 2440 | 0.030 |
Why?
| | Prenatal Care | 1 | 2019 | 309 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2006 | 5423 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1149 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2001 | 4148 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2923 | 0.020 |
Why?
| | Time Factors | 1 | 2003 | 7123 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2019 | 867 | 0.020 |
Why?
| | Risk Factors | 1 | 2005 | 10885 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2019 | 17291 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2953 | 0.020 |
Why?
|
|
Saunders's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|